FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109552359> ?p ?o ?g. }

• W2109552359 endingPage "393" @default.
• W2109552359 startingPage "381" @default.
• W2109552359 abstract "Abstract Medulloblastoma is the most common form of childhood brain tumor, and management has evolved over the past two decades. Chemotherapy is now an integral part of the treatment of the majority, if not all, patients with this disease. Medulloblastoma is a chemosensitive tumor, and recurrent disease will often respond to a variety of different chemotherapeutic agents. The use of higher-dose chemotherapy supplemented with aggressive hematological support may improve outcome for patients with recurrent disease. The results of prospective randomized trials and large, single, institutional trials in children with newly diagnosed disease suggest that chemotherapy, when given during and after radiotherapy, improves outcome. This is especially true for children with more extensive disease at the time of diagnosis. Event-free survival rates as high as 85% have been reported in children with newly diagnosed medulloblastomas treated with radiation and adjuvant chemotherapy consisting of CCNU, vincristine, and cisplatinum. At the present time, there is no clear evidence that preradiation chemotherapy improves survival for children with medulloblastoma. In fact, two prospective trials suggest that treatment with pre-irradiation chemotherapy may result in poorer overall outcome than treatment with similar doses of radiation therapy or radiation therapy supplemented by postradiation chemotherapy. There is preliminary evidence that chemotherapy may allow for a reduction in the dose of craniospinal irradiation therapy required to control disease, especially for children with nondisseminated disease at the time of diagnosis. Treatment for infants with medulloblastoma and other primitive neuroectodermal tumors remains suboptimal. Some infants and young children will experience long-term disease control after treatment with chemotherapy alone or chemotherapy followed by radiation when the child is older. High-dose chemotherapy supplemented by autologous bone marrow rescue or peripheral stem cell rescue has been utilized in young infants with promising results. The need for postchemotherapy radiation therapy and the volume of radiotherapy required to control disease remain under study." @default.
• W2109552359 created "2016-06-24" @default.
• W2109552359 creator A5025567999 @default.
• W2109552359 creator A5072346018 @default.
• W2109552359 date "1996-12-01" @default.
• W2109552359 modified "2023-10-06" @default.
• W2109552359 title "Chemotherapy for Childhood Medulloblastoma and Primitive Neuroectodermal Tumors" @default.
• W2109552359 cites W1722373994 @default.
• W2109552359 cites W1764260839 @default.
• W2109552359 cites W1833601231 @default.
• W2109552359 cites W1908846608 @default.
• W2109552359 cites W1911329365 @default.
• W2109552359 cites W1914432880 @default.
• W2109552359 cites W1922789680 @default.
• W2109552359 cites W1933116774 @default.
• W2109552359 cites W1969388710 @default.
• W2109552359 cites W1977826988 @default.
• W2109552359 cites W1980560578 @default.
• W2109552359 cites W1986557288 @default.
• W2109552359 cites W1990298357 @default.
• W2109552359 cites W1990706646 @default.
• W2109552359 cites W2000344013 @default.
• W2109552359 cites W2009539412 @default.
• W2109552359 cites W2024947250 @default.
• W2109552359 cites W2026518062 @default.
• W2109552359 cites W2026691962 @default.
• W2109552359 cites W2029871845 @default.
• W2109552359 cites W2035004196 @default.
• W2109552359 cites W2047679194 @default.
• W2109552359 cites W2048242881 @default.
• W2109552359 cites W2049454435 @default.
• W2109552359 cites W2049983595 @default.
• W2109552359 cites W2050303971 @default.
• W2109552359 cites W2051980905 @default.
• W2109552359 cites W2053165087 @default.
• W2109552359 cites W2056538167 @default.
• W2109552359 cites W2060127845 @default.
• W2109552359 cites W2062451107 @default.
• W2109552359 cites W2087008214 @default.
• W2109552359 cites W2088337704 @default.
• W2109552359 cites W2093960008 @default.
• W2109552359 cites W2104996683 @default.
• W2109552359 cites W2133893515 @default.
• W2109552359 cites W2147423434 @default.
• W2109552359 cites W2215118042 @default.
• W2109552359 cites W2227545313 @default.
• W2109552359 cites W2230642230 @default.
• W2109552359 cites W2238637976 @default.
• W2109552359 cites W2259682466 @default.
• W2109552359 cites W2285560870 @default.
• W2109552359 cites W2332556167 @default.
• W2109552359 cites W2334615503 @default.
• W2109552359 cites W2339082436 @default.
• W2109552359 cites W2884633475 @default.
• W2109552359 cites W4293775268 @default.
• W2109552359 doi "https://doi.org/10.1634/theoncologist.1-6-381" @default.
• W2109552359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10388020" @default.
• W2109552359 hasPublicationYear "1996" @default.
• W2109552359 type Work @default.
• W2109552359 sameAs 2109552359 @default.
• W2109552359 citedByCount "19" @default.
• W2109552359 countsByYear W21095523592012 @default.
• W2109552359 countsByYear W21095523592013 @default.
• W2109552359 countsByYear W21095523592014 @default.
• W2109552359 countsByYear W21095523592015 @default.
• W2109552359 countsByYear W21095523592016 @default.
• W2109552359 countsByYear W21095523592017 @default.
• W2109552359 countsByYear W21095523592019 @default.
• W2109552359 countsByYear W21095523592020 @default.
• W2109552359 crossrefType "journal-article" @default.
• W2109552359 hasAuthorship W2109552359A5025567999 @default.
• W2109552359 hasAuthorship W2109552359A5072346018 @default.
• W2109552359 hasBestOaLocation W21095523591 @default.
• W2109552359 hasConcept C121608353 @default.
• W2109552359 hasConcept C126322002 @default.
• W2109552359 hasConcept C141071460 @default.
• W2109552359 hasConcept C142724271 @default.
• W2109552359 hasConcept C143998085 @default.
• W2109552359 hasConcept C2776694085 @default.
• W2109552359 hasConcept C2776755627 @default.
• W2109552359 hasConcept C2776891213 @default.
• W2109552359 hasConcept C2778162587 @default.
• W2109552359 hasConcept C2779134260 @default.
• W2109552359 hasConcept C2779429289 @default.
• W2109552359 hasConcept C2779434656 @default.
• W2109552359 hasConcept C2780192828 @default.
• W2109552359 hasConcept C2780789225 @default.
• W2109552359 hasConcept C509974204 @default.
• W2109552359 hasConcept C71924100 @default.
• W2109552359 hasConceptScore W2109552359C121608353 @default.
• W2109552359 hasConceptScore W2109552359C126322002 @default.
• W2109552359 hasConceptScore W2109552359C141071460 @default.
• W2109552359 hasConceptScore W2109552359C142724271 @default.
• W2109552359 hasConceptScore W2109552359C143998085 @default.
• W2109552359 hasConceptScore W2109552359C2776694085 @default.
• W2109552359 hasConceptScore W2109552359C2776755627 @default.
• W2109552359 hasConceptScore W2109552359C2776891213 @default.
• W2109552359 hasConceptScore W2109552359C2778162587 @default.

• next